The Japanese GLP-1 trial administered the nasal formulation before every meal, three times daily
This makes adhering to the treatment plan simpler and increases the compliance of patients who are taking care of their diabetes, providing a sustained therapeutic effect with fewer doses
Furthermore, GLP-1R expression was visualized through three-dimensional surface plots (Figure 5C), revealing its widespread distribution within the bronchial tissue, with differences in intensity seen in different parts of the lung [11]
Enhances insulin sensitivity, improving glucose metabolism Suppresses appetite and reduces food cravings, aiding in lower calorie intake Slows gastric emptying, prolonging satiety and reducing overeating Promotes significant weight loss, even in individuals with obesity-related conditions Typical Dosage: Start with 2.5 mg once weekly, gradually 515 mg depending on patient response and tolerance Administration: Subcutaneous injection, typically in the abdomen, thigh, or upper arm Side Effects Nausea and vomiting Fatigue and mild dizziness Gastrointestinal issues Possible hypoglycemia when combined with other diabetes medications Injection site reactions, redness or irritation 3
That translates to roughly 50 pounds for someone who weighs 240 pounds
After receiving approval from the U.S